Innovative drugs in China
Innovative drugs in China China's innovative pharmaceutical sector is experiencing explosive growth, with the number of approved drugs reaching a record high in 2025 and overseas licensing deals surpa
No products available.
Sam E Drug
News Recommendation
Domestic innovative drug market shows astonishing explosive growth
Domestic innovative drug market shows astonishing explosive growth T he Chinese innovative drug market has achieved a "miraculous" growth from 2016 to 2025: the market size surged from less than 10 bi
Chengzhi Corporation's D-ribose assists in the research and development of anti epidemic drugs
In the field of medicine, D-ribose is an important intermediate and starting material for various nucleosides, anti-tumor drugs, and other drugs. Nearly 50% of antiviral drugs used in clinical practic
The new drug Culmerciclib has been launched
The new drug Culmerciclib has been launched Culmerciclib (brand name: Sitanicina®) is the first global triple inhibitor of CDK2/4/6, developed by Zhengda Tianqing under China Biopharmaceuticals. I
Vitamin E: Exploring Its Growing Applications in Dietary Supplements, Functional Foods and Cosmetics
Introduction: Why Vitamin E Remains an Important Nutritional Ingredient Vitamin E continues to play an important role in the global nutraceutical, food, and personal care industries. Recognized for it
New drug development for MM: FDA draft leads the "deep remission" era
New drug development for MM: FDA draft leads the "deep remission" era On January 20, 2026, the FDA released a draft guideline explicitly designating Minimal Residual Disease (MRD) and Complete Respons